There is also at least one hospital-based case-control histological study indicating that polymorphisms in XRCC4 may have an "influence" on prostate cancer susceptibility.
Hai tamén polo menos un estudo histolóxico dun caso control hospitalario, indicando que os polimorfismos no XRCC4 pode ter unha "influencia" na susceptibilidade do cancro de próstata.